Large equity awards granted to Aura Biosciences (AURA) director Natalie Holles
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Aura Biosciences, Inc. reported that director and officer Natalie C. Holles received significant equity awards in the form of restricted stock units, performance RSUs and stock options. She was granted 553,844 RSUs as Inducement Awards, each representing one share of common stock, vesting in four equal annual installments beginning on April 15, 2027, subject to continued service.
She also received 600,118 performance RSUs as Inducement Awards that require both time-based vesting and achievement of a performance condition. These PRSUs vest in four equal annual installments commencing on April 15, 2027 and expire on the earlier of the sixth anniversary of the grant date or the date her service with the company ends, with any unvested awards then forfeited.
In addition, Holles was granted a stock option covering 2,169,103 shares of common stock at an exercise price of $7.3900 per share, expiring on May 19, 2036. Twenty-five percent of the option vests on April 30, 2027, with the remainder vesting pro rata in 36 monthly installments, subject to continued service. Following these grants, she directly owns 1,153,962 shares of common stock.
Positive
- None.
Negative
- None.
Insider Trade Summary
3 transactions reported
Mixed
3 txns
Insider
Holles Natalie C.
Role
See Remarks
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (Right to Buy) | 2,169,103 | $0.00 | -- |
| Grant/Award | Common Stock | 600,118 | $0.00 | -- |
| Grant/Award | Common Stock | 553,844 | $0.00 | -- |
Holdings After Transaction:
Stock Option (Right to Buy) — 2,169,103 shares (Direct, null);
Common Stock — 600,118 shares (Direct, null)
Footnotes (1)
- These shares were acquired pursuant to a restricted stock unit ("RSU") award as Inducement Awards. Each RSU represents the right to receive one share of the Issuer's common stock. These RSUs vest in four substantially equal annual installments beginning on April 15, 2027, subject to the Reporting Person's continued service as of each such vesting date. These shares were acquired pursuant to a performance RSU ("PRSU") award as Inducement Awards. The PRSUs are subject to both time-based vesting and the achievement of a performance condition, both of which must be satisfied before the PRSUs will be deemed vested. The PRSUs shall vest in four substantially equal annual installments commencing on April 15, 2027, subject to Ms. Holles' continued service as of each such time-based vesting date and the satisfaction of the performance condition. The expiration date of the PRSUs is the earlier of (i) the sixth (6th) anniversary of the grant date and (ii) the date Ms. Holles no longer has a service relationship with the Issuer. Any such PRSUs that have not vested on or prior to such expiration date shall be forfeited for no consideration. The shares underlying this option vest as follows: 25% of the shares vest on April 30, 2027 with the remainder vesting thereafter pro-rata in 36 monthly installments, subject to the Reporting Person's continued service as of each such vesting date.
Key Figures
RSU grant: 553,844 shares
Performance RSU grant: 600,118 shares
Stock option size: 2,169,103 shares
+3 more
6 metrics
RSU grant
553,844 shares
RSU Inducement Award vesting annually from April 15, 2027
Performance RSU grant
600,118 shares
PRSU Inducement Award with time and performance conditions
Stock option size
2,169,103 shares
Option to buy common stock granted to Holles
Option exercise price
$7.3900 per share
Exercise price of stock option expiring May 19, 2036
Option expiration
May 19, 2036
Expiration date of stock option grant
Post-award holdings
1,153,962 shares
Common stock directly owned after non-derivative acquisitions
Key Terms
restricted stock unit ("RSU"), performance RSU ("PRSU"), Inducement Awards, service relationship, +1 more
5 terms
restricted stock unit ("RSU") financial
"These shares were acquired pursuant to a restricted stock unit ("RSU") award as Inducement Awards."
performance RSU ("PRSU") financial
"These shares were acquired pursuant to a performance RSU ("PRSU") award as Inducement Awards."
Inducement Awards financial
"These shares were acquired pursuant to a restricted stock unit ("RSU") award as Inducement Awards."
Inducement awards are special bonuses given to new employees to encourage them to join a company, often in the form of stock or money. They matter because they can motivate talented people to choose one company over another and help align their success with the company's growth. Think of it like a signing bonus to seal the deal.
service relationship financial
"the date Ms. Holles no longer has a service relationship with the Issuer."
Stock Option (Right to Buy) financial
"Stock Option (Right to Buy)"
FAQ
What equity awards did Natalie C. Holles receive from Aura Biosciences (AURA)?
Natalie C. Holles received RSUs, performance RSUs, and stock options from Aura Biosciences. She was granted 553,844 RSUs, 600,118 performance RSUs, and a stock option for 2,169,103 shares, all as Inducement Awards tied to multi-year vesting schedules and continued service.
How do the RSUs granted to Natalie C. Holles at Aura Biosciences vest?
The 553,844 RSUs granted to Holles vest over four years starting April 15, 2027. They vest in four substantially equal annual installments, and each RSU converts into one share of Aura Biosciences common stock, assuming she continues serving through each vesting date.
What conditions apply to Natalie C. Holles’ performance RSUs at Aura Biosciences (AURA)?
The 600,118 performance RSUs require both time-based vesting and meeting a performance condition. They vest in four equal annual installments beginning April 15, 2027, only if Holles remains in service and the specified performance condition is satisfied before the awards are deemed vested.
What are the key terms of Natalie C. Holles’ stock option grant from Aura Biosciences?
Holles received a stock option to buy 2,169,103 Aura Biosciences shares at $7.39. Twenty-five percent vests on April 30, 2027, with the remaining portion vesting pro rata over 36 monthly installments, and the option expires on May 19, 2036, subject to continued service.
When do Natalie C. Holles’ performance RSUs at Aura Biosciences expire if unvested?
The performance RSUs expire at the earlier of six years from grant or her service ending. Any performance RSUs that have not vested by the sixth anniversary or by the time she no longer has a service relationship with Aura Biosciences are forfeited for no consideration.